首页|期刊导航|中国中医药科技|黄芪甲苷通过Nrf2/HO-1 通路减轻缺血性脑卒中大鼠氧化应激损伤及改善眩晕症状的机制

黄芪甲苷通过Nrf2/HO-1 通路减轻缺血性脑卒中大鼠氧化应激损伤及改善眩晕症状的机制OA

The Mechanism of Astragaloside Ⅳ Reducing Oxidative Stress Injury and Improving Vertigo Symptoms in Rats with Ischemic Stroke Through Nrf2/HO-1 Pathway

中文摘要英文摘要

目的:探究黄芪甲苷通过核因子E2 相关因子 2(Nrf2)/血红素氧合酶-1(HO-1)通路减轻缺血性脑卒中大鼠氧化应激损伤及改善眩晕症状的机制.方法:60 只SD大鼠,随机分成假手术组(sham组)、模型组(MCAO组)、阳性对照组(XST组)、黄芪甲苷组(ASⅣ组)、Nrf2 激活剂组(Hesperin组)、Nrf2抑制剂组(Brusatol组),每组10 只.除sham组外均建立大脑中动脉栓塞模型(MCAO).sham组、MCAO组不予任何干预.XST 组用血塞通胶囊灌胃(3.15 mg/kg),ASIV 组以黄芪甲苷灌胃(20 mg/kg),Hesperin组黄芪甲苷灌胃(20 mg/kg)+注射Hesperin(10 mg/kg),Brusatol组黄芪甲苷灌胃(20 mg/kg)+注射Brusatol(2 mg/kg),均连续干预7d.干预后,Zea Longa评分、Garcia JH评分评价神经功能,记录并比较各组大鼠体质量;离心机和跳台仪观察眩晕症状;化学比色法检测海马组织丙二醛(MDA)、超氧化物歧化酶(SOD)、谷胱甘肽(GSH)、氧化型谷胱甘肽(GSSG)含量;HE染色观察额叶前端脑组织形态;免疫印迹检测 HO-1、Nrf2 蛋白表达.结果:与 sham 组比较,MCAO 组、XST 组、ASIV 组、Hesperin 组、Brusatol组Zea Longa评分、潜伏期、MDA、GSSG水平升高,Garcia JH评分、体质量、旋转时间、SOD、GSH水平、Nrf2、HO-1 蛋白表达降低(P<0.05).与MCAO组比较,XST组、ASIV组、Hesperin组Zea Longa评分、潜伏期、MDA、GSSG水平降低,Hesperin组最低(P<0.05),Garcia JH评分、体质量、旋转时间、SOD、GSH水平、Nrf2、HO-1 蛋白表达升高,Hesperin组最高(P<0.05),MCAO组与Brusatol组无显著差异(P>0.05).MCAO组、Brusatol组细胞排列紊乱,细胞间存在大量炎性浸润.XST组、ASIV组、Hesperin组细胞排列趋于规律,Hesperin组形态最佳.结论:黄芪甲苷有利于改善缺血性脑卒中大鼠的神经功能与眩晕症状,改善氧化应激,其作用机制可能与激活Nrf2/HO-1 信号通路有关.

Objective:To explore the mechanism of astragaloside Ⅳ in reducing oxidative stress injury and improving vertigo symptoms in rats with ischemic stroke through nuclear factor E2-related factor 2(Nrf2)/heme oxygenase-1(HO-1)pathway.Methods:Sham operation group(sham group),model group(MCAO group),positive control group(XST group),ASIV group,Nrf2 activator group(Hesperin group),Nrf2 inhibitor group(Brusatol group)(10 rats in each group).Middle cerebral artery occlusion(MCAO)model was established in all groups except sham group.Sham group and MCAO group were not given any intervention.The XST group was given Xuesaitong capsule by gavage(3.15 mg/kg),the ASIV group was given astragaloside Ⅳ by gavage(20 mg/kg),the Hesperin group was given astragaloside Ⅳ by gavage(20 mg/kg)+injection of Hesperin(10 mg/kg),and the Brusatol group was given astragaloside Ⅳ by gavage(20 mg/kg)+injection of Brusatol(2 mg/kg).All groups were continuously intervened for 7 days.After intervention,Zea Longa score and Garcia JH score were used to evaluate neurological function.Centrifuge and jumping instrument were used to observe vertigo symptoms,the body weight of rats in each group was recorded and compared;the contents of malondialdehyde(MDA),superoxide dismutase(SOD),glutathione(GSH)and oxidized glutathione,glutathione disulfide(GSSG)in hippocampus were detected by chemical colorimetry.HE staining was used to observe the morphology of frontal lobe brain tissue.The expression of HO-1 and Nrf2 protein was detected by Western blot.Results:Compared with sham group,Zea Longa score,latency,MDA and GSSG levels in MCAO group,XST group,ASIV group,Hesperin group and Brusatol group were increased,Garcia JH score,body weight,rotation time,SOD,GSH levels,Nrf2 and HO-1 protein expression were decreased(P<0.05).Compared with MCAO group,Zea Longa score,latency,MDA and GSSG levels in XST group,ASIV group and Hesperin group decreased,and those in Hesperin group were the lowest(P<0.05).Garcia JH score,body weight,rotation time,SOD,GSH levels,Nrf2 and HO-1 protein expression increased,and those in Hesperin group were the highest(P<0.05).There was no significant difference between MCAO group and Brusatol group(P>0.05).The cells in the MCAO group and the Brusatol group were disordered,and there was a large amount of inflammatory infiltration between the cells.The arrangement of cells in XST group,ASIV group and Hesperin group tended to be regular,and the morphology of Hesperin group was the best.Conclusion:Astragaloside Ⅳ is beneficial to improve neurological function and vertigo symptoms in rats with ischemic stroke,improve oxidative stress.The mechanism may be related to the activation of Nrf2/HO-1 signaling pathway.

阮佳佳;赵薇;何振宇;赖文芳

台州市中西医结合医院·浙江 台州 317511台州市中西医结合医院·浙江 台州 317511台州市中西医结合医院·浙江 台州 317511台州市中西医结合医院·浙江 台州 317511

黄芪甲苷缺血性脑卒中氧化应激核因子E2 相关因子2血红素氧合酶-1

astragaloside Ⅳischemic strokeoxidative stressnuclear factor E2 related factor 2heme oxygenase-1

《中国中医药科技》 2026 (3)

217-222,6

国家自然科学基金资助项目(82174001)

评论